Gut bacteria may control development of hepatocellular carcinoma

Affiliations

¹ The Third Department of Internal Medicine, Toyama University Hospital, Toyama, Japan.
² Gastroenterology Center, Nanto Municipal Hospital, Nanto, Toyama, Japan.

Editorial

Kazuto Tajiri et al. Hepatobiliary Surg Nutr. 2017 Dec.

. 2017 Dec;6(6):417-419.

doi: 10.21037/hbsn.2017.07.05.

¹ The Third Department of Internal Medicine, Toyama University Hospital, Toyama, Japan.
² Gastroenterology Center, Nanto Municipal Hospital, Nanto, Toyama, Japan.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice.
Li J, Sung CY, Lee N, Ni Y, Pihlajamäki J, Panagiotou G, El-Nezami H. Li J, et al. Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1306-15. doi: 10.1073/pnas.1518189113. Epub 2016 Feb 16. Proc Natl Acad Sci U S A. 2016. PMID: 26884164 Free PMC article.

1. Minemura M, Shimizu Y. Gut microbiota and liver diseases. World J Gastroenterol 2015;21:1691-702. 10.3748/wjg.v21.i6.1691 - DOI - PMC - PubMed
1. Bauché D, Marie JC. Transforming growth factor β: a master regulator of the gut microbiota and immune cell interactions. Clin Transl Immunology 2017;6:e136. 10.1038/cti.2017.9 - DOI - PMC - PubMed
1. Usami M, Miyoshi M, Yamashita H. Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol 2015;21:11597-608. 10.3748/wjg.v21.i41.11597 - DOI - PMC - PubMed
1. Imajo K, Fujita K, Yoneda M, et al. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab 2012;16:44-54. 10.1016/j.cmet.2012.05.012 - DOI - PubMed
1. Wong VW, Won GL, Chim AM, et al. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol 2013;12:256-62. - PubMed